PLK1 and neoplasm: AS1411-aptamer-targeted CDEH nanoparticles efficiently inhibit tumor progression as a result of intracellular saporin-specific delivery; folate-targeting CDEH nanoparticles effectively suppress tumor growth on account of joint Cas9 protein and Plk1-targeting sgRNA-selected delivery.